Want to see STRO full AI Analyst Report?
Sutro Biopharma (STRO) Q3 2018 Earnings Report
STRO Q3 2018 EPS Results
- Actual EPS
- -$21.26
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$0.06
STRO Q3 2018 Revenue Results
- Actual Revenue
- $7.84M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2018
- Date
- 11/14/2018
- Time
- TBA
- Conference Call
- Wednesday, November 14, 2018
STRO Upcoming Earnings
Sutro Biopharma's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q3 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
STRO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2026 (Q3) | -1.64- | -6.7 | ― | ― |
| Aug 12, 2026 | 2026 (Q2) | -2.19-2.33 | -1.4 | -66.43% (-0.93) | |
| May 14, 2026 | 2026 (Q1) | -2.74-2.94 | -9.1 | 67.69% (+6.16) | |
| Mar 23, 2026 | 2025 (Q4) | -8.16-5.29 | -8.3 | 36.27% (+3.01) | |
| Nov 06, 2025 | 2025 (Q3) | -3.94-6.70 | -5.9 | -13.56% (-0.80) | |
| Aug 07, 2025 | 2025 (Q2) | -3.82-1.40 | -5.9 | 76.27% (+4.50) | |
| May 08, 2025 | 2025 (Q1) | -6.43-9.10 | -9.5 | 4.21% (+0.40) | |
| Mar 13, 2025 | 2024 (Q4) | -8.30-8.30 | 5.2 | -259.62% (-13.50) | |
| Nov 13, 2024 | 2024 (Q3) | -7.35-5.90 | -8.1 | 27.16% (+2.20) | |
| Aug 13, 2024 | 2024 (Q2) | -7.92-5.90 | -6.4 | 7.81% (+0.50) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed